Recent developments in the discovery of melanin-concentrating hormone antagonists: Novel antiobesity agents

Expert Opinion on Therapeutic Patents

Volumn 14, Issue 3, 2004, Pages 313-325

  Browning, Andrew ^a  

^a BIOVITRUM AB   (Sweden)

Author keywords

Energy homeostasis; GPR24; MCH1R; Melanin concentrating hormone (MCH); Obesity; SLC 1

Indexed keywords

2 AMINOQUINOLINE; 4 AMINOQUINOLINE; 4 AMINOQUINOLINE DERIVATIVE; ACETAMIDE DERIVATIVE; ACETYL COENZYME A ACYLTRANSFERASE; AMIDE; ANILIDE; ANTIOBESITY AGENT; APPETITE STIMULANT; BENZAMIDE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZOFURAN DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CHLOROQUINE; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR; HORMONE ANTAGONIST; INDOLE DERIVATIVE; ISOINDOLE DERIVATIVE; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE ANTAGONIST; OXADIAZOLE DERIVATIVE; OXAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA DERIVATIVE;

ANOREXIA; ANXIETY DISORDER; BACTERIAL INFECTION; BODY WEIGHT; BULIMIA; DEPRESSION; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; ENERGY BALANCE; EXPERIMENTAL MODEL; FEEDING BEHAVIOR; FOOD INTAKE; HORMONE STRUCTURE; HUMAN; METABOLIC SYNDROME X; MOLECULAR WEIGHT; MYCOSIS; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOPOROSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; RODENT; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; URINARY TRACT DISEASE; URINE RETENTION; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 1642335643     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.14.3.313     Document Type: Review

References (53)

1. KAWAUCHI H, KAWAZOE I, TSUBOKAWA M, KISHIDA M, BAKER BI: Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature (1983) 305:321-323.
2. SKOFITSCH G, JACOBOWITZ DM, ZAMIR N: Immunohistochemical localization of a melanin-concentrating hormone-like peptide in the rat brain. Brain Res. Bull. (1985) 15:635-649.
3. VAUGHAN JM, FISCHER WH, HOEGER C, RIVIER J, VALE W: Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 125:1660-1665.
4. PRESSE F, NAHON JL, FISCHER WH, VALE W: Structure of the human melanin concentrating hormone mRNA. Mol. Endocrinol. (1990) 4:632-637.
5. GONZALEZ MI, BAKER BI, HOLE DR, WILSON CA: Behavioral effects of neuropeptide E-I (NEI) in the female rat: Interactions with α-MSH, MCH and dopamine. Peptides (1998) 19:1007-1016.
6. SANCHEZ M, BAKER BI, CELIS M: Melanin-concentrating hormone (MCH) antagonizes the effects of α-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides (1997) 18:393-396.
7. CHAMBERS J, AMES RS, BERGSMA D et al.: Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 400:261-265.
8. SHIMOMURA Y, MORI M, SUGO T et al.: Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem. Biophys. Res. Comm. (1999) 261:622.
9. BACHNER D, KREIENKAMP H-J, WEISE C, BUCK F, RICHTER D: Identification of melanin-concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. (1999) 457:522-524.
10. SAITO Y, NOTHACKER H-P, WANG Z et al.: Molecular characterization of the melanin-concentrating-hormone receptor. Nature (1999) 400:265-269.
11. KOLAKOWSKI LF Jr, JUNG BP, NGUYEN T et al.: Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. (1996) 398:253-258.
12. HERVIEU G, CLUDERAY J, HARRISON D et al.: The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eu. J. Neurosci. (2000) 12:1194-1216.
13. WANG S, BEHAN J, O'NEILL K et al.: Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. J. Biol. Chem. (2001) 276:34664-34670.
14. HILL J, DUCKWORTH M, MURDOCK P et al.: Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. (2001) 276:20125-20129.
15. MORI M, HARADA M, TERAO Y et al.: Cloning of a novel G-protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem. Biophys. Res. Commun. (2001) 283:1013-1018.
16. SAILER AW, SANO H, ZENG Z et al.: Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. PNAS (2001) 98:7564-7569.
17. AN S, CUTLER G, ZHAO JJ et al.: Identification and characterization of a melanin-concentrating hormone receptor. PNAS(2001) 98:7576-7581.
18. TAN CP, SANO H, IWAASA H et al.: Melanin-concentrating hormone receptor subtypes 1 and 2: Species-specific gene expression. Genomics (2002) 79:785-792.
19. BOUTIN JA, SUPLY T, AUDINOT V et al.: Melanin-concentrating hormone and its receptors: State of the art. Can. J. Physiol. Pharmacol. (2002) 80:388-385.
20. MACDONALD D, MURGOLO N, ZHANG R et al.: Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. Mol. Pharmacol. (2000) 58:217-225.
21. BEFORT K, ZILLIOX C, FILLIOL D, YUE S, KIEFFER BL: Constitutive activation of the δ-opioid receptor by mutations in transmembrane domains III and VII. J. Biol. Chem. (1999) 274:18574-18581.
22. SURRATT CK, JOHNSON PS, MORIWAKI A et al.: μ-Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. (1994) 269:20548-20553.
23. NEHRING RB, MEYERHOF W, RICHTER D: Aspartic add residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol. (1995) 14:939-944.
24. BEDNAREK MA, FEIGHNER SD, HRENIUK DL et al.: Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2. Biochemistry (2001) 40:9379-9386.
25. AUDINOT V, BEAUVERGER P, LAHAYE C et al.: Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor. J. Biol. Chem. (2001) 276:13554-13562.
26. 125I-S36057: A new and highly potent radioligand for the melanin-concentrating hormone receptor. Br. J. Pharmacol. (2001) 133:371-378.
27. SUPLY T, DELLA ZUANA O, AUDINOT V et al.: SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: A structure-activity study. J. Pharmacol. Exp. Ther. (2001) 299:137-146.
28. QU D, LUDWIG DS, GAMMELTOFT S et al.: A role for melanin-concentrating hormone in die central regulation of feeding behavior. Nature (1996) 380:243-247.
29. TORRI C, PEDRAZZI P, LEO G et al.: Diet-induced changes in hypothalamic proopio-melanocortin mRNA in the rat hypothalamus. Peptides (2002) 23:1063-1068.
30. GAO J, GHIBAUDI L, VAN HEEK M, HWA JJ: Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fit followed by 1 month of low-fat diet. Brain Res. Bull. (2002) 936:87-90.
31. ROSSI M, CHOI SJ, O'SHEA D et al.: Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 138:351-355.
32. GOMORI A, ISHIHARA A, ITO M et al.: Chronic intracerebroventricular infusion of MCH causes obesity in mice. Am. J. Physiol. (2003) 284:E583-E588.
33. ITO M, GOMORI A. ISHIHARA A et al.: Characterization of MCH-mediated obesity in mice. Am. J. Physiol. (2003) 284:E940-E945.
34. PRESSE F, NAHON JL: Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rat. Neuroscience (1993) 55:709-720.
35. SHEARMAN LP, CAMACHO RE, SLOAN STRIBLING D et al.: Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eu. J. Pharmacol. (2003) 475:37-47.
36. SHIMADA M, TRITOS NA, LOWELL BB, FLIER JS, MARATOS-FLIER E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 396:670-674.
37. SEGAL-LIEBERMAN G, BRADLEY RL, KOKKOTOU E et al.: Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. PNAS (2003) 100:10085-10090.
38. LUDWIG DS, TRITOS NA, MASTAITIS JW et al.: Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Invest. (2001) 107:379-386.
39. CHEN Y, HU C, HSU C-K et al.: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143:2469-2477.
40. MARSH DJ, WEINGARTH DT, NOVI DE et al.: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. PNAS (2002) 99:3240-3245.
41. TAKEAAWA S, ASAMI A, ISHIHARA Y et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eu. J. Pharmacol. (2002) 438:1239-1135.
42. BOROWSKY B, DURKIN MM, OGOZALEK K et al.: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. (2002) 8:825-830.
43. CARPENTER AJ, HERTZOG DL: Melanin-concentrating hormone receptor antagonists as potential antiobesity agents. Expert Opin. Ther. Patents (2002) 12:1639-1646.
44. MOKDAD AH, BOWMAN BA, FORD ES et al.: The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. (2001) 286:1195-2000.
45. WILLETT WC, DIETZ WH, COLDITZ GA: Guidelines for healthy weight. N. Engl. J. Med. (1999) 341:427-434.
46. FORD ES, WILLIAMSON DF, LIU S: Weight change and diabetes incidence: Findings from a national cohort of US adults. Am. J. Epidemiol. (1997) 146:214-212.
47. HELMRICH SP, RAGLAND DR, LEUNG RW, PAFFENBARGER RS: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. (1991) 325:147-152.
48. MCCARRON DA, REUSSER ME: Reducing cardiovascular disease risk with diet. Obesity Res. (2001) 9:335S-340S.
49. TUOMILEHTO J, LINDSTROM J, ERIKSSON JG et al.: Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med (2001) 344:1343-1350.
50. MONTAGUE CT, FAROOQI IS, WHITEHEAD JP et al.: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 387:903-907.
51. FAROOQI IS, YEO GSH, KEOGH JM et al.: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. (2000) 106:271-279.
52. VAISSE C, CLEMENT K, GUY-GRAND B, FROGUEL P: A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. (1998) 20:113-114.
53. VAISSE C, CLEMENT K, DURAND E et al.: Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity J. Clin. Invest. (2000) 106:253-262.